1
Evolution and Risk Factors Associated With Geographic Atrophy Progression
Condition(s):Geographic AtrophyLast Updated:March 24, 2015Completed
Geographic Atrophy: 159 Clinical Trials, Page 1 of 16
Hide Studies Not Open or Pending
2
A Study of Lampalizumab Intravitreal Injections Administered Every Two Weeks or Every Four Weeks to Participants With Geographic Atrophy
Condition(s):Geographic AtrophyLast Updated:September 25, 2019Completed
3
Geographic Atrophy and Intravitreal Ranibizumab Injections
Condition(s):Age-related Macular Degeneration; Geographic AtrophyLast Updated:February 26, 2015Unknown status
4
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
Condition(s):Geographic AtrophyLast Updated:October 10, 2018Unknown status
5
CLG561 Proof-of-Concept Study as a Monotherapy and in Combination With LFG316 in Subjects With Geographic Atrophy (GA)
Condition(s):Geographic AtrophyLast Updated:May 30, 2019Completed
6
Zimura in Subjects With Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration
Condition(s):Geographic Atrophy; Macular DegenerationLast Updated:October 19, 2020Completed
7
A Study of Disease Progression in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Condition(s):Geographic AtrophyLast Updated:August 20, 2019Terminated
8
A Study of Disease Progression in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Condition(s):Geographic AtrophyLast Updated:August 9, 2019Terminated
9
Intravitreal Injections of Sirolimus in the Treatment of Geographic Atrophy
Condition(s):Geographic AtrophyLast Updated:December 10, 2015Terminated
10
A Study Investigating the Efficacy and Safety of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Condition(s):Geographic AtrophyLast Updated:June 26, 2019Terminated